關於inflammatory myositis 的myositis specific antibodies 與臨床表現，下列敘述何者最不適當？
anti–MDA5 antibodies：amyopathic dermatomyositis with digital ulcers
anti–NXP–2 antibodies：higher risk of cancer
anti–Mi–2 antibodies：a favorable response to treatment
anti–TIF1–γ antibodies：lower risk of cancer
